A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.

Saved in:

Bibliographic Details
Title:	A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.
Authors:	Bafaloukos, Dimitrios¹, Linardou, Helena¹ elinardou@otenet.gr, Aravantinos, Gerasimos², Papadimitriou, Christos³, Bamias, Aristotelis³, Fountzilas, George⁴, Kalofonos, Haralabos P.⁵, Kosmidis, Paris⁶, Timotheadou, Eleni⁴, Makatsoris, Thomas⁵, Samantas, Epaminondas², Briasoulis, Evangelos⁷, Christodoulou, Christos⁸, Papakostas, Pavlos⁹, Pectasides, Dimitrios¹⁰, Dimopoulos, Athanasios M.³
Source:	BMC Medicine. 2010, Vol. 8, Special section p1-12. 12p. 2 Diagrams, 5 Charts, 1 Graph.
Database:	Academic Search Ultimate

Description
ISSN:	17417015
DOI:	10.1186/1741-7015-8-3